Vir Biotechnology, Inc.
VIR
$6.12
-$0.17-2.70%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 905.35M | 914.47M | 1.15B | 1.15B | 1.52B |
| Total Receivables | 5.10M | 5.30M | 7.20M | 4.10M | 11.60M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 42.63M | 37.79M | 33.53M | 45.90M | 40.95M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 89.39M | 89.60M | 13.95M | 13.34M | 13.27M |
| Total Current Assets | 1.04B | 1.05B | 1.21B | 1.21B | 1.59B |
|
|
|||||
| Total Current Assets | 1.04B | 1.05B | 1.21B | 1.21B | 1.59B |
| Net Property, Plant & Equipment | 122.86M | 125.57M | 128.33M | 162.82M | 167.20M |
| Long-term Investments | 16.94M | 16.94M | 16.94M | 16.94M | 16.94M |
| Goodwill | 16.94M | 16.94M | 16.94M | 16.94M | 16.94M |
| Total Other Intangibles | 8.12M | 19.26M | 18.90M | 22.47M | 22.57M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.42M | 17.94M | 19.66M | 18.92M | 18.86M |
| Total Assets | 1.40B | 1.50B | 1.67B | 1.79B | 1.92B |
|
|
|||||
| Total Accounts Payable | 5.08M | 7.31M | 4.39M | 7.11M | 6.33M |
| Total Accrued Expenses | 66.53M | 65.53M | 48.21M | 52.60M | 82.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.75M | 19.41M | 19.50M | 11.91M | 12.87M |
| Total Finance Division Other Current Liabilities | 40.30M | 24.92M | 24.32M | 22.44M | 74.06M |
| Total Other Current Liabilities | 40.30M | 24.92M | 24.32M | 22.44M | 74.06M |
| Total Current Liabilities | 119.66M | 117.16M | 96.41M | 94.07M | 175.41M |
|
|
|||||
| Total Current Liabilities | 119.66M | 117.16M | 96.41M | 94.07M | 175.41M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 90.14M | 93.41M | 95.02M | 109.17M | 111.67M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 38.63M | 47.06M | 44.46M | 43.37M | 41.74M |
| Total Liabilities | 248.43M | 257.63M | 235.89M | 246.61M | 328.82M |
|
|
|||||
| Common Stock & APIC | 1.91B | 1.89B | 1.88B | 1.85B | 1.83B |
| Retained Earnings | -759.78M | -655.20M | -441.48M | -303.10M | -237.82M |
| Treasury Stock & Other | -1.72M | 1.13M | -2.88M | -2.40M | -815.00K |
| Total Common Equity | 1.15B | 1.24B | 1.43B | 1.55B | 1.59B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.15B | 1.24B | 1.43B | 1.55B | 1.59B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.15B | 1.24B | 1.43B | 1.55B | 1.59B |
|
|
|||||